银戈利德B-环氧德克斯林包容复合物:一种封装策略,用于改善支气管喘中的可溶性和气溶吸入治疗
Yuying Wang1, MingLi Wei2, Yan Zhang3
1School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, 11016, Liaoning, China.
Drug delivery and translational research
|March 14, 2026
概括
金科利德B环极衍生物通过增强吸入的生物可用性来改善喘治疗. 这些化合物有效地减少了呼吸道炎症,并减轻了小鼠的喘症状.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 支气管喘是一种慢性呼吸道炎症,其特点是异氨基细胞的积累.
- 银科利德B (GB),一个血小板激活因子对手,显示出喘管理的潜力,但其生物可用性较差.
- 低水溶性和苦味限制了口服银戈利德B的治疗效果.
研究的目的:
- 通过气溶吸入开发新型的金戈利德B (GB) 衍生物,用于有效的支气管喘治疗.
- 通过循环德克斯特林复合,增强金科利德B的生物可用性和治疗潜力.
- 在临床前喘模型中评估GB-环氧德克斯含量化合物的疗效和安全性.
主要方法:
- 开发了两种银戈利德B-环极衍生物:GB-SBE-β-CD和GB-HP-γ-CD.
- 分子对接分析以阐明包容复合体的结合相互作用和空间结构.
- 在体外细胞测试以评估GB及其衍生物的安全性和抗炎活性.
- 使用OVA诱导的喘模型在BALB/c小鼠中的体内研究,以评估吸入GB-cyclopodextrin气溶的治疗效果.
主要成果:
- SBE-β-CD和HP-γ-CD成功地封装了Ginkgolide B,形成了稳定的包含化合物.
- 分子对接证实了结作为驱动复合体形成的主要相互作用.
- 实验室研究表明,GB及其环极素复合体具有良好的安全性和强大的抗炎作用.
- 吸入GB-SBE-β-CD和GB-HP-γ-CD显著减少了小鼠的呼吸道炎症和缓解了喘症状.
结论:
- 银戈利德B-环极地含化合物提供了一个有前途的策略,以克服银戈利德B的生物可用性限制.
- 这些衍生物的气溶吸入提供了一种安全有效的方法来管理支气管喘.
- 这种新的配方代表了在治疗炎症性呼吸道疾病方面的潜在进步.
相关概念视频
01:23Inhaled Medications
952
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
952
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
296
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
296
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K